Multiple myeloma depth of response to therapy at different stages
The epigenetics of multiple myeloma and the rationale for HDAC inhibitors
Lymphoma: chemotherapy vs. bendamustine
Mathias J Rummel
Mantle cell lymphoma highlights from ASH 2016: Lysa, PHILEMON results and more
Do immunoglobulin receptor interactions play a role in CLL?